Evidence map›Paper›PMID 31207946›Full record

ArticleJournal of clinical medicine2019

MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV Infection.

Óscar Brochado-Kith, Alicia Gómez Sanz, Luis Miguel Real, Javier Crespo García, Pablo Ryan Murúa, Juan Macías, Joaquín Cabezas González, Jesús Troya, Juan Antonio Pineda, María Teresa Arias Loste and 7 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Differential miRNA signatures in Hepatitis E Virus Infection: Insights into acute, chronic, and pregnancy-related outcomes.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Review
  2. Comparison of Extracellular Vesicle Isolation Methods for miRNA Sequencing.International journal of molecular sciences · 2023
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Óscar Brochado-KithUnit of Viral Infection and Immunity, National Center for Microbiology, Institute of Health Carlos III, Majadahonda, 28220 Madrid, Spain. obrochado@isciii.es.ORCID 0000-0001-8372-2604
Alicia Gómez SanzUnit of Viral Infection and Immunity, National Center for Microbiology, Institute of Health Carlos III, Majadahonda, 28220 Madrid, Spain. agsmm73@hotmail.com.
Luis Miguel RealUnidad Clínica de Enfermedades Infecciosas, Hospital Universitario de Valme, 41014 Sevilla, Spain. lmreal67b@gmail.com.ORCID 0000-0003-4932-7429
Javier Crespo GarcíaGastroenterology and Hepatology Department, Hospital Universitario Marques de Valdecilla, 39008 Santander, Spain. javiercrespo1991@gmail.com.
Pablo Ryan MurúaInternal Medicine Service, University Hospital Infanta Leonor, School of Medicine, Complutense University of Madrid, Gregorio Marañón Health Research Institute, 28009 Madrid, Spain. pabloryan@gmail.com.
Juan MacíasUnidad Clínica de Enfermedades Infecciosas, Hospital Universitario de Valme, 41014 Sevilla, Spain. juan.macias.sanchez@gmail.com.
Joaquín Cabezas GonzálezGastroenterology and Hepatology Department, Hospital Universitario Marques de Valdecilla, 39008 Santander, Spain. joaquin.cabezas@scsalud.es.ORCID 0000-0003-0012-484X
Jesús TroyaInternal Medicine Service, University Hospital Infanta Leonor, School of Medicine, Complutense University of Madrid, Gregorio Marañón Health Research Institute, 28009 Madrid, Spain. jestrogar@hotmail.com.ORCID 0000-0001-7323-114X
Juan Antonio PinedaUnidad Clínica de Enfermedades Infecciosas, Hospital Universitario de Valme, 41014 Sevilla, Spain. japineda@telefonica.net.
María Teresa Arias LosteGastroenterology and Hepatology Department, Hospital Universitario Marques de Valdecilla, 39008 Santander, Spain. mteresa.arias@scsalud.es.ORCID 0000-0001-8864-3833
Victorino Díez ViñasInternal Medicine Service, University Hospital Infanta Leonor, School of Medicine, Complutense University of Madrid, Gregorio Marañón Health Research Institute, 28009 Madrid, Spain. victorino.diez@gmail.com.
María Ángeles Jiménez-SousaUnit of Viral Infection and Immunity, National Center for Microbiology, Institute of Health Carlos III, Majadahonda, 28220 Madrid, Spain. jimenezsousa@isciii.es.
Luz María Medrano de DiosUnit of Viral Infection and Immunity, National Center for Microbiology, Institute of Health Carlos III, Majadahonda, 28220 Madrid, Spain. luzmedranodios@gmail.com.ORCID 0000-0003-3717-5384
Isabel Cuesta De la PlazaBioinformatics Unit, Unidades Comunes Científico Técnicas, Institute of Health Carlos III, Majadahonda, 28220 Madrid, Spain. isabel.cuesta@isciii.es.
Sara Monzón FernándezBioinformatics Unit, Unidades Comunes Científico Técnicas, Institute of Health Carlos III, Majadahonda, 28220 Madrid, Spain. smonzon@isciii.es.
Salvador Resino GarcíaUnit of Viral Infection and Immunity, National Center for Microbiology, Institute of Health Carlos III, Majadahonda, 28220 Madrid, Spain. sresino@isciii.es.ORCID 0000-0001-8783-0450
Amanda Fernández-RodríguezUnit of Viral Infection and Immunity, National Center for Microbiology, Institute of Health Carlos III, Majadahonda, 28220 Madrid, Spain. amandafr@isciii.es.ORCID 0000-0002-5110-2213
Instituto de Salud Carlos III · ESHospital Universitario de Valme · ESUniversidad Complutense de Madrid · ESUniversidad de Cantabria · ES

Funding

Instituto de Salud Carlos III CP14/0010
6 · The paper itself

Abstract

Factors involved in the spontaneous cleareance of a hepatitis C (HCV) infection are related to both HCV and the interaction with the host immune system, but little is known about the consequences after a spontaneous resolution. The main HCV extrahepatic reservoir is the peripheral blood mononuclear cells (PBMCs), and their transcriptional profile provides us information of innate and adaptive immune responses against an HCV infection. MicroRNAs regulate the innate and adaptive immune responses, and they are actively involved in the HCV cycle. High Throughput sequencing was used to analyze the miRNA profiles from PBMCs of HCV chronic naïve patients (CHC), individuals that spontaneously clarified HCV (SC), and healthy controls (HC). We did not find any differentially expressed miRNAs between SC and CHC. However, both groups showed similar expression differences (21 miRNAs) with respect to HC. This miRNA signature correctly classifies HCV-exposed (CHC and SC) vs. HC, with the has-miR-21-3p showing the best performance. The potentially targeted molecular pathways by these 21 miRNAs mainly belong to fatty acids pathways, although hippo signaling, extracellular matrix (ECM) interaction, proteoglycans-related, and steroid biosynthesis pathways were also altered. These miRNAs target host genes involved in an HCV infection. Thus, an HCV infection promotes molecular alterations in PBMCs that can be detected after an HCV spontaneous resolution, and the 21-miRNA signature is able to identify HCV-exposed patients (either CHC or SC).

Indexed as

chronic hepatitis Clipid metabolismMicroRNAsspontaneous HCV clarification

Identifiers

PMID31207946
PMCPMC6617112
OpenAlexW2952355463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.